Shortening HIV vaccine regimens to achieve high coverage

Lancet HIV. 2020 Jun;7(6):e377-e378. doi: 10.1016/S2352-3018(20)30039-4. Epub 2020 Feb 17.

Authors

Maria Blasi¹, Genevieve G Fouda²

Affiliations

¹ Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
² Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: genevieve.fouda@duke.edu.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

AIDS Vaccines*
Animals
Double-Blind Method
HIV Infections*
HIV-1 / immunology*
Humans
Macaca mulatta

Substances

AIDS Vaccines

Grants and funding